Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
In the world of billion-dollar particle physics, one lab is taking an enormous gamble on its future. Geoff Brumfiel takes a look at Fermilab's hopes to host the next big machine.
Siberia's vast forests absorb huge quantities of carbon from the atmosphere. But how much, and will they continue to do so in a warming world? Quirin Schiermeier speaks to the carbon accountants.
Scientific research can be tricky at the best of times, but people with disabilities face additional challenges both in the lab and when dealing with data. Jessica Ebert meets the researchers who are building their own customized solutions to overcome these problems.
A mysterious disease that causes children's brains to melt away is caused by errors in RNA translation. But biologists are realizing that this horrifying condition could shed light on more common problems. Claire Ainsworth reports.
Drugs that could lessen the death toll in a flu pandemic do exist. But global stockpiles are too small, and the countries at most immediate risk are among the worst prepared. Alison Abbott reports.
Welcome to my weblog. I'm Sally O'Reilly, a freelance journalist based in Washington DC. I've been researching a book on pandemic preparedness. But now the time for preparation has run out.
Stem cells are engaged in constant crosstalk with their environment, biologists are fast realizing. So the emerging field of regenerative medicine is now wrestling with the ecological concept of the niche. Kendall Powell reports.
An Islamic theocracy ravaged by economic sanctions isn't an obvious place to seek a vibrant cognitive-neuroscience research group. Yet that's what Alison Abbott found on a recent trip to Iran.
A new generation of planetary radar aims to look deeper than ever into some of the Solar System's most enduring mysteries. Tony Reichhardt gets ready for a trip to the interior.
As construction on the world's largest optical telescope nears completion in Spain, the country's astronomers are gearing up for an expanded role on the global stage. Mark Peplow follows the preparations for first light.
Companies and scientists in the West are keen to test their drugs in China, which is an important future market. But those running clinical trials need to be on their guard, says David Cyranoski.
Are wafers of silicon that support cells cultured from vital organs the future of drug testing and toxicology? Roxanne Khamsi talks to the pioneers creating model animals — and humans — on a chip.
Growing numbers of people are being implanted with electronic devices that can automatically restart a failing heart. But have the risks and benefits been adequately assessed? Duncan Graham-Rowe investigates.
From meeting the Dalai Lama to national media star, Anton Zeilinger is on a mission to bring physics to a wider audience. Quirin Schiermeier listens in.
The intelligent-design movement is a small but growing force on US university campuses. For some it bridges the gap between science and faith, for others it goes beyond the pale. Geoff Brumfiel meets the movement's vanguard.
Digital photography and image-manipulation software allow biologists to tweak their data as never before. But there's a fine line between acceptable enhancements and scientific misconduct. Helen Pearson investigates.
A steady stream of mechanical animals is marching out of the lab into the field. Jonathan Knight tunes in to see how these motorized models can expose what makes real creatures behave the way they do.
